The news report also points to differences between Neuralink and rival Synchron, which has taken a BCI to treat neurological diseases that has already advanced into clinical trials. Animal testing ...

Neuralink is a neurotechnology startup that ... have amassed nearly US$1.5 billion in funding. One competitor is Synchron, a company with similar ambitions that has received funding from the ...

The South China Morning Post reports today that brain-computer interface (BCI) startup StairMed brought in $48 million in ...

Launched in August last year, the BCI is even smaller than Neuralink's chip. Synchron, founded by Tom Oxley who has performed more than 1,600 endovascular neurosurgical procedures, is also making ...

Neuralink is currently seeking additional volunteers ... dozens of implants into patients – as well as Paradromics and Synchron.